All Things Male > Fitness, Wellness, Bodybuilding & General Health > All Things Male > PubMed - TRT

Pages : [1] 2 3

1. Breast cancer risk in postmenopausal women using testosterone in combination with hor
2. Testosterone and gonadotropins but not estrogen associated with spatial ability in wo
3. Testosterone Replacement Therapy and Motor Function in Men with Spinal Cord Injury: A
4. Low testosterone levels in patients with mild hypertension recovered after antidepres
5. Replacement therapy for Addison's disease: recent developments.
6. Exogenous testosterone alone or with finasteride does not improve measurements of cog
7. Diagnosis and treatment of female sexual dysfunction.
8. Effects of testosterone replacement and its pharmacogenetics on physical performance
9. Androgenic-anabolic steroids and the Olympic Games.
10. Androgen abuse in sports.
11. [Hormone therapy and anti-aging: is there an indication?]
12. Selective androgen receptor modulators for frailty and osteoporosis.
13. Hypoactive sexual desire in transsexual women: prevalence and association with testos
14. Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled
15. Erectile dysfunction in men receiving methadone and buprenorphine maintenance treatme
16. Androgen deficiency: effects on body composition.
17. Current and future testosterone delivery systems for treatment of the hypogonadal mal
18. Cortical bone loss in androgen-deficient aged male rats is mainly caused by increased
19. Effects of the addition of methyltestosterone to combined hormone therapy with estrog
20. Bone density and turnover in young adult patients with growth hormone deficiency afte
21. Androgen deficiency as a predictor of metabolic syndrome in aging men: an opportunity
22. Gonadal hormone modulation of the behavioral effects of Delta9-tetrahydrocannabinol i
23. Testosterone protects rat hearts against ischaemic insults by enhancing the effects o
24. Is discontinuation of hormone replacement therapy possible for patients with late-ons
25. Prostate Tissue Androgens: History and Current Clinical Relevance.
26. The association of endogenous sex hormones with lipoprotein subfraction profile in th
27. Sex steroids and vascular responses in hypertension and aging.
28. CaV3.2 T-type calcium channels are involved in calcium-dependent secretion of neuroen
29. The effects of testosterone on sleep and sleep-disordered breathing in men: Its bidir
30. A case of synchronous bilateral testicular seminoma.
31. Clinical practice experience with testosterone treatment in men with testosterone def
32. Dimethandrolone (7alpha,11beta-dimethyl-19-nortestosterone) and 11beta-methyl-19-nort
33. [Torsion of the spermatic cord after prophylactic orchidopexy]
34. [Erectile dysfunction and obstructive sleep apnea syndrome]
35. Disorders of sex development: Hormonal management in adolescence.
36. The relationship between hypogonadism and erectile dysfunction.
37. Testosterone replacement in men.
38. Contralateral intratubular germ cell neoplasia in a patient with testicular cancer.
39. The Associations Between Serum Sex Hormones, Erectile Function, and Sex Drive: The Ol
40. Effects of an early postnatal treatment of hypogonadotropic hypogonadism with a conti
41. [Pathogenesis, diagnosis and treatment of osteoporosis in men]
42. Androgen Replacement in Men Undergoing Treatment for Prostate Cancer.
43. Effect of testosterone on morphine withdrawal syndrome in rats.
44. Testosterone and depression in men.
45. The medicalisation of male menopause in America.
46. [Therapy of male hypogonadism]
47. Music facilitate the neurogenesis, regeneration and repair of neurons.
48. Validation of a high throughput method for serum/plasma testosterone using liquid chr
49. Osteoporosis quiz. A question of bone health.
50. Assessing hypogonadism in men - How helpful are current testosterone assays?
51. Persistence of androgenic effects on the production of proinflammatory cytokines by c
52. Gender and the injured brain.
53. Testosterone replacement in ageing men.
54. Complete Androgen Insensitivity Syndrome.
55. Uropharmacology for the primary care physician.
56. Testosterone replacement therapy for the primary care physician.
57. Associations between serum testosterone levels, cell proliferation and progesterone r
58. Control of childhood congenital adrenal hyperplasia and sleep activity and quality wi
59. Drugs and prolactin.
60. Androgen receptor CAG repeat polymorphism is associated with serum testosterone level
61. Neonatal gonadectomy and adult testosterone replacement suggest an involvement of lim
62. Pharmacological management of children with short stature: the role of aromatase inhi
63. Increases in bone mineral density in response to oral dehydroepiandrosterone replacem
64. [Treatment of erectile dysfunction in patients with plastic induration of the penis]
65. The effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual
66. Hypogonadotrophic hypogonadism in type 2 diabetes.
67. Experts offer advice on testosterone testing and whether to discontinue hormone thera
68. A cross-sectional analysis of testosterone therapies in hypopituitary men on stable p
69. Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and b
70. Estrogen receptor-alpha signaling in growth of the ventral prostate: comparison of ne
71. CDC project on standardizing steroid hormone measurements.
72. Androgen replacement therapy in androgen-deficient women with hypopituitarism.
73. Correlation between simultaneous PSA and serum testosterone concentrations among eugo
74. Effects of ovariectomy or orchidectomy and estradiol valerate or testosterone enantha
75. Effects of corticosterone deficiency and its replacement on Leydig cell steroidogenes
76. Gender difference, sex hormones, and immediate type hypersensitivity reactions.
77. Hyperandrogenism after transfer of topical testosterone gel: case report and review o
78. Testosterone and the prostate: implications for the treatment of hypogonadal men.
79. In vivo microMRI-based finite element and morphological analyses of tibial trabecular
80. Androgens and prostate cancer risk.
81. Drug-induced gynecomastia.
82. Aggressive behaviors in adult SF-1 knockout mice that are not exposed to gonadal ster
83. One-year therapy with 10mg/day DHEA alone or in combination with HRT in postmenopausa
84. Dehydroepiandrosterone replacement therapy in hypoadrenal women: protein anabolism an
85. Metformin-responsive classic salt-losing congenital adrenal hyperplasia due to 21-hyd
86. Six-month administration of 1% testosterone gel is able to restore erectile function
87. Advances in testosterone replacement therapy.
88. Testosterone in obesity, metabolic syndrome and type 2 diabetes.
89. Testosterone and coronary artery disease.
90. Erectile dysfunction and testosterone deficiency.
91. Testosterone, bone and osteoporosis.
92. Testosterone effects on cognition in health and disease.
93. Testosterone in chronic heart failure.
94. Are the adverse effects of glitazones linked to induced testosterone deficiency?
95. Case Report: Treatment of Androgen Deficiency in the Aging Male.
96. Ultrastructural and proliferative features of the ventral lobe of the prostate in non
97. Cognitive effects of hormonal therapy in older adults.
98. Deleted
99. Testosterone replacement therapy and motor function in men with spinal cord injury.
100. Advances in hormone replacement therapy: making the menopause manageable.
101. The presence and role of progesterone receptor in the ovaries of postmenopausal women
102. Sexuality and the menopause.
103. Men's Health, Low Testosterone, and Diabetes: Individualized Treatment and a Multidis
104. Sexual function in young women with spontaneous 46,XX primary ovarian insufficiency.
105. Pilot study: absorption and efficacy of multiple hormones delivered in a single cream
106. Regulation of atherosclerotic plaque growth and stability by testosterone and its rec
107. Levels of sex steroid and cardiovascular disease measures in premenopausal and hormon
108. [Testosterone replacement In hypogonadotropic hypogonadal young male improves insulin
109. Postoperative pituitary hormonal disturbances and hormone replacement therapy time an
110. Sexually dimorphic effects of testosterone administration on brain allopregnanolone i
111. Gender and the endothelium.
112. British Society for Sexual Medicine guidelines on the management of erectile dysfunct
113. The role of accurate testosterone testing in the treatment and management of male hyp
114. Treating men's health holistically: protecting endothelial function early.
115. Guilt by association: a historical perspective on Huggins, testosterone therapy, and
116. Sex hormones and mucosal wound healing.
117. Increased blood pressure in mice lacking cytochrome P450 2J5.
118. Testosterone Gel Monotherapy Improves Sexual Function of Hypogonadal Men Mainly Throu
119. Modulators of vascular sex hormone receptors and their effects in estrogen-deficiency
120. The activation of heat shock transcription factor 1 is differentially regulated in th
121. Testosterone therapy improves the clinical response to conventional treatment for mal
122. Endothelial effects of drugs designed to treat erectile dysfunction.
123. Mood, hormones and quality of life.
124. [Andrological testosterone replacement therapy.]
125. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with
126. Testosterone replacement therapy in the climacteric: Benefits beyond sexuality.
127. Combination of hormone replacement therapy and high physical activity is associated w
128. Testosterone Replacement Therapy in Naturally and Surgically Menopausal Women (CME).
129. Effect of androgens combined with hormone therapy on quality of life in post-menopaus
130. Testosterone supplementation for hypogonadal men by the nasal route.
131. Effect of testosterone replacement therapy on arterial stiffness in older hypogonadal
132. Salivary steroid assays - research or routine?
133. [Acquired male hypogonadotropic hypogonadism (MHH) in a patient with empty sella: a c
134. The management of hypogonadism in aging male patients.
135. Influence of estrogen plus testosterone supplementation on breast cancer.
136. The effects of testosterone on cognition in elderly men: a review.
137. Tissue engineered testicular prostheses with prolonged testosterone release.
138. Hormones in wellness and disease prevention: common practices, current state of the e
139. Age and hormone replacement therapy as factors influencing androgen levels in the pos
140. Preoperative assessment for pituitary surgery.
141. Androgens and Erectile Function: A Case for Early Androgen Use in Postprostatectomy H
142. Testosterone Replacement Therapy Following Radical Prostatectomy.
143. [French urologist's opinion on testosterone deficiency syndrome: Afu's andrology comm
144. Advances in the management of testosterone deficiency. Introduction.
145. Anabolic applications of androgens for functional limitations associated with aging a
146. Oral testosterone replacement in symptomatic late-onset hypogonadism - effects on rat
147. The effects of treating male hypogonadism on couples' sexual desire and function.
148. [Effects of different treatments on endothelial function in patients with erectile dy
149. Diagnosis of adrenocortical tumor in a neonate by detection of elevated blood 17-hydr
150. Assessment of puberty in relation to L-carnitine and hormonal replacement therapy in
151. Postmenopausal estrogen-containing hormone therapy and the risk of breast cancer.
152. Web-based survey on the effect of menopause on women's libido in a computer-literate
153. Safety of testosterone use in women.
154. Estradiol replacement in gonadectomized male rats alters scopolamine-induced disrupti
155. Testosterone patches for female sexual dysfunction.
156. Profile of the progesterone derivative chlormadinone acetate - pharmocodynamic proper
157. A Randomized Phase 1 Study of Testosterone Replacement for Patients with Low-Risk Cas
158. testosterone replacement therapy; +24 new citations
159. Temporal trends in testosterone levels and treatment in older men.
160. Hypogonadotropic hypogonadism in men with type 2 diabetes.
161. Hydrocortisone treatment in girls with congenital adrenal hyperplasia inhibits serum
162. [A case of complete androgen insensitivity syndrome]
163. Vascular endothelial growth factor and breast cancer risk.
164. Inflammation and epithelial alterations in rat prostate: impact of the androgen to oe
165. Long term benefits of testosterone replacement therapy on angina thresholdand atherom
166. Endocrine consequences of opioid therapy.
167. Following the common association between testosterone deficiency and diabetes mellitu
168. Absorption of Testosterone Gel 1% (Testim) from Three Different Application Sites.
169. Exogenous transforming growth factor beta1 replacement and fertility in male Tgfb1 nu
170. Giving men a boost.
171. [Sexual dysfunction in male: a matter of old age or a warning signal?]
172. [Pathogenesis, evaluation and treatment of hypogonadism in men.]
173. Testosterone replacement does not normalize carcass composition in chronically decere
174. Effects of dehydroepiandrosterone replacement on vascular function in primary and sec
175. [Diagnosis and therapy of male hormonal changes related to aging]
176. The effects of hormone replacement therapy on autoimmune disease: rheumatoid arthriti
177. [Kallmann syndrome--a form of hypogonadotropic hypogonadism]
178. Testosterone and depression: systematic review and meta-analysis.
179. Prolonged oestrogen treatment does not correlate with a sustained increase in anterio
180. Effects of bilateral ovariectomy and estrogen replacement therapy on serum leptin, se
181. Mammary gland and endometrial effects of testosterone in combination with oral estrad
182. Effect of aromatizable and unaromatizable androgen replacement in hypogonadal men on
183. Should women receive androgen replacement therapy, and if so, how?
184. Factors other than sex steroids modulate GHRH and GHRP-2 efficacies in men: evaluatio
185. Hypothyroidism secondary to hypothalamic-pituitary dysfunction may be part of the phe
186. The estrogen-injected female mouse: new insight into the etiology of PCOS.
187. LEI (Lack of tEstosterone Impact) survey in a clinical sample with surgical menopause
188. The relation between urinary incontinence and steroid hormone levels in perimenopausa
189. Pharmacogenetics of testosterone replacement therapy.
190. A randomized, double-blind, placebo-controlled study of testosterone treatment in hyp
191. Effects of transdermal testosterone or oral dydrogesterone on hypoactive sexual desir
192. Acute hepatitis induced by replacement oral testosterone product in a female-to-male
193. [LOH (late-onset hypogonadism) or the "aging male"]
194. Sex steroid hormones in diabetes-induced sexual dysfunction: focus on the female gend
195. Protective actions of sex steroid hormones in Alzheimer's disease.
196. The role of testosterone in women.
197. Clomiphene Citrate and Testosterone Gel Replacement Therapy for Male Hypogonadism: Ef
198. Testosterone treatment diminishes sickness behavior in male songbirds.
199. Natural hormone therapy for menopause.
200. Giant prolactinoma: Efficacy of medical management.
201. The benefits and risks of testosterone replacement therapy: a review.
202. Aromatase deficiency in men: a clinical perspective.
203. Patient scenario: a 53-year-old woman with hypoactive sexual desire disorder.
204. Testosterone replacement therapy: what to look for, when to treat.
205. Adiponectin and testosterone in patients with symptoms of late-onset hypogonadism: Is
206. Comparative effects of conventional hormone replacement therapy and tibolone on clima
207. Relationship Between Higher Estradiol Levels and 9-Year Mortality in Older Women: The
208. Increased prevalence of prolonged QT interval in males with primary or secondary hypo
209. [Antipsychotics and hyperpolactinaemia: pathophysiology, clinical relevance, diagnosi
210. Serum testosterone is associated with aggressive prostate cancer in older men: result
211. Fatty acid metabolism in the elderly: effects of dehydroepiandrosterone and testoster
212. Antiandrogenic activities of Glycyrrhiza glabra in male rats.
213. Editorial comment on: Shifting the paradigm of testosterone and prostate cancer: the
214. The role of testosterone in the management of hypoactive sexual desire disorder in po
215. The Association of Endogenous Sex Hormones, Adiposity, and Insulin Resistance with In
216. Subcutaneous Testosterone Pellet Implant (Testopel) Therapy for Men with Testosterone
217. Testosterone Concentrations in Hair of Hypogonadal Men With and Without Testosterone
218. The Effect of Testosterone Replacement Therapy on Bladder Functions and Histology in
219. Effects of Aromatase Inhibition on Bone Mineral Density and Bone Turnover in Older Me
220. Hyperthyroidism unmasked several years after the medical and radiosurgical treatment
221. Androgen replacement therapy and cardiovascular function.
222. Different cardiovascular effects of progestins according to structure and activity.
223. The impact of sex hormone changes on bone mineral deficit in chronic renal failure.
224. Growth hormone and sex steroid effects on serum glucose, insulin, and lipid concentra
225. Androgen Replacement Therapy in Turner Syndrome: A Pilot Study.
226. Re: Christina Wang, Eberhard Nieschlag, Ronald Swerdloff, et al. Investigation, treat
227. The emerging link between hypogonadism and metabolic syndrome.
228. Phase 1 trial of high-dose exogenous testosterone in patients with castration-resista
229. Testosterone therapy and prostate carcinoma.
230. The causes and prevalence of hypoactive sexual desire disorder: part I.
231. Should testosterone replacement be given to men with large prostates?
232. Salivary sex hormone measurement in a national, population-based study of older adult
233. 'What should I do with a 60 year old man with a slightly low serum total testosterone
234. [Delayed puberty.]
235. Randomized cross-over clinical trial of injectable vs. implantable depot testosterone
236. Opportunities for intervention in HSDD.
237. Testosterone replacement in prostate cancer survivors with hypogonadal symptoms.
238. Clomiphene citrate and enclomiphene for the treatment of hypogonadal androgen deficie
239. Safety and efficacy of testosterone gel in the treatment of male hypogonadism.
240. Summaries for patients. Hormonal testing and pharmacologic treatment of erectile dysf
241. Hormonal testing and pharmacologic treatment of erectile dysfunction: a clinical prac
242. Oral phosphodiesterase-5 inhibitors and hormonal treatments for erectile dysfunction:
243. Re: testosterone levels among men with spinal cord injury: relationships between time
244. Sarcopenia--mechanisms and treatments.
245. [Erectile dysfunction after radical prostatectomy]
246. Testosterone stimulates extra-hepatic but not hepatic fat oxidation (Fox): comparison
247. Effect of testosterone, raloxifene and estrogen replacement on the microstructure and
248. [Androgen replacement therapy improves health-related quality of life in late onset h
249. The ability of stress to alter sleep in mice is sensitive to reproductive hormones.
250. Testosterone replacement.